7 completed, 2 unknown. 6 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 5, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow N Acetylcysteine: new trials by email Literature Review of N Acetylcysteine trials Research Report on N Acetylcysteine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization. N Acetylcysteine, Dexamethasone, Placebo - Hepatocellular Carcinoma | Not applicable | Unknown | Institute of Liver and Biliary Sciences, India | 150 | 2023-09-15 | 2023-09-15 |
| Drug Nephrotoxicity Amelioration by N-acetylcysteine N Acetylcysteine - Drug-Induced Nephropathy | Not applicable | Completed | Helwan University | 100 | 2023-08-25 | 2024-07-05 |
| N-acetylcysteine Reduces Acetaldehyde Levels in Binge Alcohol Drinking N Acetylcysteine, Lemon juice - Ethanol Intoxication | Not applicable | Completed | University Medical Centre Ljubljana | 40 | 2021-06-01 | 2023-06-22 |
| Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy N Acetylcysteine - Diabetic Kidney Disease, Diabetes Mellitus, Type 2 | Phase 2 / Phase 3 | Unknown | Al-Azhar University | 60 | 2019-10-01 | 2020-08-28 |
| Memory and Antioxidants in Vascular Impairment Trial N Acetylcysteine, Placebo oral capsule - Vascular Cognitive Impairment no Dementia | Phase 2 | Completed | Sunnybrook Health Sciences Centre | 60 | 2018-04-30 | 2025-03-26 |
| Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer N Acetylcysteine, Placebo Oral Tablet - Cisplatin Adverse Reaction, Hearing Loss Ototoxic | Not applicable | Completed | Hospital San Juan de Dios, Santiago | 45 | 2015-11-01 | 2018-01-17 |
| Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) Progressive exercise, Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV, Modified paleolithic diet - Multiple Sclerosis | Phase 1 | Completed | University of Iowa | 38 | 2010-10-01 | 2018-06-26 |
| Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity N Acetylcysteine - Hepatitis, Tuberculosis | Not applicable | Completed | National Research Institute of Tuberculosis and Lung Disease, Iran | 60 | 2007-11-01 | 2009-04-22 |
| Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine n acetylcysteine, sodium bicarbonate, sodium chloride - Acute Renal Failure Contrast Nephropathy | Not applicable | Completed | Shaare Zedek Medical Center | 250 | 2005-01-01 | 2010-02-25 |
Carcinoma, Hepatocellular (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Nephropathies (1) · Hepatitis (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1) · Ototoxicity (1) · Tuberculosis (1)
Al-Azhar University (1) · Helwan University (1) · Hospital San Juan de Dios, Santiago (1) · Institute of Liver and Biliary Sciences, India (1) · National Research Institute of Tuberculosis and Lung Disease, Iran (1) · Shaare Zedek Medical Center (1) · Sunnybrook Health Sciences Centre (1) · University Medical Centre Ljubljana (1) · University of Iowa (1)
Egypt (2) · Canada (1) · Chile (1) · India (1) · Iran (1) · Israel (1) · Slovenia (1) · United States (1)
Huda M. Salem, PhD (1) · Miran Brvar, MD (1) · Shadi Baniasadi, PhD (1)